UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Tuberculosis vaccines: Rising opportunities

PLoS medicine, 2019-04, Vol.16 (4), p.e1002791-e1002791

2019

Volltextzugriff (PDF)

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

Vaccine, 2019-11, Vol.37 (50), p.7394-7395

2019

Volltextzugriff (PDF)

Research and development of new tuberculosis vaccines: a review [version 1; peer review: 3 approved, 1 approved with reservations]

F1000 research, 2018, Vol.7, p.1732

2018

Volltextzugriff (PDF)

From the circumsporozoite protein to the RTS,S/AS candidate vaccine

Human vaccines, 2010-01, Vol.6 (1), p.90-96

2010

Volltextzugriff (PDF)

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

International journal of infectious diseases, 2022-01, Vol.114, p.165-174

2022

Volltextzugriff (PDF)

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.2355-2355

2016

Volltextzugriff (PDF)

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

The Lancet global health, 2019-12, Vol.7 (12), p.e1655-e1663

2019

Volltextzugriff (PDF)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

Frontiers in immunology, 2017-05, Vol.8, p.557-557

2017

Volltextzugriff (PDF)

Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert survey [version 1; peer review: 2 approved]

F1000 research, 2019, Vol.8, p.1685-1685

2019

Volltextzugriff (PDF)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

The Lancet infectious diseases, 2011-02, Vol.11 (2), p.102-109

2011

Volltextzugriff (PDF)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

Frontiers in immunology, 2021-07, Vol.12, p.694759-694759

2021

Volltextzugriff (PDF)

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications

The Journal of infectious diseases, 2013-02, Vol.207 (3), p.511-519

2013

Volltextzugriff (PDF)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children

PloS one, 2014, Vol.9 (12), p.e115126-e115126

2014

Volltextzugriff (PDF)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E

PloS one, 2012-12, Vol.7 (12), p.e52870-e52870

2012

Volltextzugriff (PDF)

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine

PloS one, 2017-03, Vol.12 (3), p.e0173294-e0173294

2017

Volltextzugriff (PDF)

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine

Malaria journal, 2011-08, Vol.10 (1), p.223-223, Article 223

2011

Volltextzugriff (PDF)

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon

PloS one, 2009-10, Vol.4 (10), p.e7611-7611

2009

Volltextzugriff (PDF)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Malaria journal, 2011-08, Vol.10 (1), p.224-224, Article 224

2011

Volltextzugriff (PDF)

Research and development of new tuberculosis vaccines: a review [version 2; peer review: 3 approved, 1 approved with reservations]

F1000 research, 2018-01, Vol.7, p.1732-1732

2018

Volltextzugriff (PDF)

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1464-1470

2020

Volltextzugriff (PDF)

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites

PloS one, 2011-06, Vol.6 (6), p.e21711-e21711

2011

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(170)
Buchkapitel
(6)

Sprache

Englisch
(175)
Japanisch
(10)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(108)
Science & Technology
(104)
Life Sciences & Biomedicine
(96)
Malaria
(67)
Vaccines
(66)
Infectious Diseases
(54)
Immunology
(53)
Female
(45)
Infant
(40)
Immunization
(37)
Malaria Vaccines - Immunology
(37)
Infections
(36)
Plasmodium Falciparum
(35)
Microbiology
(30)
Male
(29)
Vaccination
(29)
Children
(28)
Malaria, Falciparum - Prevention & Control
(27)
Plasmodium Falciparum - Immunology
(26)
Adult
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tuberculosis vaccines: Rising opportunities

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

Research and development of new tuberculosis vaccines: a review [version 1; peer review: 3 approved, 1 approved with reservations]

From the circumsporozoite protein to the RTS,S/AS candidate vaccine

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; peer review: 2 approved]

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert survey [version 1; peer review: 2 approved]

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E

Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Research and development of new tuberculosis vaccines: a review [version 2; peer review: 3 approved, 1 approved with reservations]

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)

Suchergebnisse filtern